KBP-7909

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameKBP-7909
Drug Alias NameKBP-7909
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Hengli Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Hengli Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A